Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease : the iPOWER study. / Mygind, Naja Dam; Michelsen, Marie Mide; Peña, Adam; Ali Qayyum, Abbas; Frestad, Daria; Christensen, Thomas Emil; Ghotbi, Adam Ali; Dose, Nynne; Faber, Rebekka; Vejlstrup, Niels; Hasbak, Philip; Kjær, Andreas; Prescott, Eva; Kastrup, Jens; steering committee of the iPower study.

In: Journal of Cardiovascular Magnetic Resonance, Vol. 18, 76, 04.11.2016.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mygind, ND, Michelsen, MM, Peña, A, Ali Qayyum, A, Frestad, D, Christensen, TE, Ghotbi, AA, Dose, N, Faber, R, Vejlstrup, N, Hasbak, P, Kjær, A, Prescott, E, Kastrup, J & steering committee of the iPower study 2016, 'Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study', Journal of Cardiovascular Magnetic Resonance, vol. 18, 76. https://doi.org/10.1186/s12968-016-0295-5

APA

Mygind, N. D., Michelsen, M. M., Peña, A., Ali Qayyum, A., Frestad, D., Christensen, T. E., Ghotbi, A. A., Dose, N., Faber, R., Vejlstrup, N., Hasbak, P., Kjær, A., Prescott, E., Kastrup, J., & steering committee of the iPower study (2016). Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. Journal of Cardiovascular Magnetic Resonance, 18, [76]. https://doi.org/10.1186/s12968-016-0295-5

Vancouver

Mygind ND, Michelsen MM, Peña A, Ali Qayyum A, Frestad D, Christensen TE et al. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. Journal of Cardiovascular Magnetic Resonance. 2016 Nov 4;18. 76. https://doi.org/10.1186/s12968-016-0295-5

Author

Mygind, Naja Dam ; Michelsen, Marie Mide ; Peña, Adam ; Ali Qayyum, Abbas ; Frestad, Daria ; Christensen, Thomas Emil ; Ghotbi, Adam Ali ; Dose, Nynne ; Faber, Rebekka ; Vejlstrup, Niels ; Hasbak, Philip ; Kjær, Andreas ; Prescott, Eva ; Kastrup, Jens ; steering committee of the iPower study. / Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease : the iPOWER study. In: Journal of Cardiovascular Magnetic Resonance. 2016 ; Vol. 18.

Bibtex

@article{a6d631129fee4057a02755085dae2feb,
title = "Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study",
abstract = "BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR) and by positron emission tomography measuring myocardial blood flow reserve (MBFR). Diffuse myocardial fibrosis can be assessed by cardiovascular magnetic resonance (CMR) T1 mapping. We hypothesized that coronary microvascular disease is associated with diffuse myocardial fibrosis.METHODS: Women with angina, a clinically indicated coronary angiogram with <50 % stenosis and no diabetes were included. CFVR was measured using dipyridamole (0.84 mg/kg) and MBFR using adenosine (0.84 mg/kg). Focal fibrosis was assessed by 1.5 T CMR late gadolinium enhancement (0.1 mmol/kg) and diffuse myocardial fibrosis by T1 mapping using a modified Look-Locker pulse sequence measuring T1 and extracellular volume fraction (ECV).RESULTS: CFVR and CMR were performed in 64 women, mean (SD) age 62.5 (8.3) years. MBFR was performed in a subgroup of 54 (84 %) of these women. Mean native T1 was 1023 (86) and ECV (%) was 33.7 (3.5); none had focal fibrosis. Median (IQR) CFVR was 2.3 (1.9; 2.7), 23 (36 %) had CFVR < 2 indicating coronary microvascular disease, and median MBFR was 2.7 (2.2; 3.0) and 19 (35 %) had a MBFR value below 2.5. No significant correlations were found between CFVR and ECV or native T1 (R (2)  = 0.02; p = 0.27 and R (2)  = 0.004; p = 0.61, respectively). There were also no correlations between MBFR and ECV or native T1 (R (2)  = 0.1; p = 0.13 and R (2)  = 0.004, p = 0.64, respectively). CFVR and MBFR were correlated to hypertension and heart rate.CONCLUSION: In women with angina and no obstructive coronary artery disease we found no association between measures of coronary microvascular disease and myocardial fibrosis, suggesting that myocardial ischemia induced by coronary microvascular disease does not elicit myocardial fibrosis in this population. The examined parameters seem to provide independent information about myocardial and coronary disease.",
author = "Mygind, {Naja Dam} and Michelsen, {Marie Mide} and Adam Pe{\~n}a and {Ali Qayyum}, Abbas and Daria Frestad and Christensen, {Thomas Emil} and Ghotbi, {Adam Ali} and Nynne Dose and Rebekka Faber and Niels Vejlstrup and Philip Hasbak and Andreas Kj{\ae}r and Eva Prescott and Jens Kastrup and {steering committee of the iPower study}",
year = "2016",
month = nov,
day = "4",
doi = "10.1186/s12968-016-0295-5",
language = "English",
volume = "18",
journal = "Journal of Cardiovascular Magnetic Resonance",
issn = "1097-6647",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease

T2 - the iPOWER study

AU - Mygind, Naja Dam

AU - Michelsen, Marie Mide

AU - Peña, Adam

AU - Ali Qayyum, Abbas

AU - Frestad, Daria

AU - Christensen, Thomas Emil

AU - Ghotbi, Adam Ali

AU - Dose, Nynne

AU - Faber, Rebekka

AU - Vejlstrup, Niels

AU - Hasbak, Philip

AU - Kjær, Andreas

AU - Prescott, Eva

AU - Kastrup, Jens

AU - steering committee of the iPower study

PY - 2016/11/4

Y1 - 2016/11/4

N2 - BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR) and by positron emission tomography measuring myocardial blood flow reserve (MBFR). Diffuse myocardial fibrosis can be assessed by cardiovascular magnetic resonance (CMR) T1 mapping. We hypothesized that coronary microvascular disease is associated with diffuse myocardial fibrosis.METHODS: Women with angina, a clinically indicated coronary angiogram with <50 % stenosis and no diabetes were included. CFVR was measured using dipyridamole (0.84 mg/kg) and MBFR using adenosine (0.84 mg/kg). Focal fibrosis was assessed by 1.5 T CMR late gadolinium enhancement (0.1 mmol/kg) and diffuse myocardial fibrosis by T1 mapping using a modified Look-Locker pulse sequence measuring T1 and extracellular volume fraction (ECV).RESULTS: CFVR and CMR were performed in 64 women, mean (SD) age 62.5 (8.3) years. MBFR was performed in a subgroup of 54 (84 %) of these women. Mean native T1 was 1023 (86) and ECV (%) was 33.7 (3.5); none had focal fibrosis. Median (IQR) CFVR was 2.3 (1.9; 2.7), 23 (36 %) had CFVR < 2 indicating coronary microvascular disease, and median MBFR was 2.7 (2.2; 3.0) and 19 (35 %) had a MBFR value below 2.5. No significant correlations were found between CFVR and ECV or native T1 (R (2)  = 0.02; p = 0.27 and R (2)  = 0.004; p = 0.61, respectively). There were also no correlations between MBFR and ECV or native T1 (R (2)  = 0.1; p = 0.13 and R (2)  = 0.004, p = 0.64, respectively). CFVR and MBFR were correlated to hypertension and heart rate.CONCLUSION: In women with angina and no obstructive coronary artery disease we found no association between measures of coronary microvascular disease and myocardial fibrosis, suggesting that myocardial ischemia induced by coronary microvascular disease does not elicit myocardial fibrosis in this population. The examined parameters seem to provide independent information about myocardial and coronary disease.

AB - BACKGROUND: Even in absence of obstructive coronary artery disease women with angina pectoris have a poor prognosis possibly due to coronary microvascular disease. Coronary microvascular disease can be assessed by transthoracic Doppler echocardiography measuring coronary flow velocity reserve (CFVR) and by positron emission tomography measuring myocardial blood flow reserve (MBFR). Diffuse myocardial fibrosis can be assessed by cardiovascular magnetic resonance (CMR) T1 mapping. We hypothesized that coronary microvascular disease is associated with diffuse myocardial fibrosis.METHODS: Women with angina, a clinically indicated coronary angiogram with <50 % stenosis and no diabetes were included. CFVR was measured using dipyridamole (0.84 mg/kg) and MBFR using adenosine (0.84 mg/kg). Focal fibrosis was assessed by 1.5 T CMR late gadolinium enhancement (0.1 mmol/kg) and diffuse myocardial fibrosis by T1 mapping using a modified Look-Locker pulse sequence measuring T1 and extracellular volume fraction (ECV).RESULTS: CFVR and CMR were performed in 64 women, mean (SD) age 62.5 (8.3) years. MBFR was performed in a subgroup of 54 (84 %) of these women. Mean native T1 was 1023 (86) and ECV (%) was 33.7 (3.5); none had focal fibrosis. Median (IQR) CFVR was 2.3 (1.9; 2.7), 23 (36 %) had CFVR < 2 indicating coronary microvascular disease, and median MBFR was 2.7 (2.2; 3.0) and 19 (35 %) had a MBFR value below 2.5. No significant correlations were found between CFVR and ECV or native T1 (R (2)  = 0.02; p = 0.27 and R (2)  = 0.004; p = 0.61, respectively). There were also no correlations between MBFR and ECV or native T1 (R (2)  = 0.1; p = 0.13 and R (2)  = 0.004, p = 0.64, respectively). CFVR and MBFR were correlated to hypertension and heart rate.CONCLUSION: In women with angina and no obstructive coronary artery disease we found no association between measures of coronary microvascular disease and myocardial fibrosis, suggesting that myocardial ischemia induced by coronary microvascular disease does not elicit myocardial fibrosis in this population. The examined parameters seem to provide independent information about myocardial and coronary disease.

U2 - 10.1186/s12968-016-0295-5

DO - 10.1186/s12968-016-0295-5

M3 - Journal article

C2 - 27809867

VL - 18

JO - Journal of Cardiovascular Magnetic Resonance

JF - Journal of Cardiovascular Magnetic Resonance

SN - 1097-6647

M1 - 76

ER -

ID: 173125776